[HTML][HTML] Antibodies against low-density lipoprotein receptor–related protein 4 induce myasthenia gravis
C Shen, Y Lu, B Zhang, D Figueiredo… - The Journal of …, 2013 - Am Soc Clin Investig
Myasthenia gravis (MG) is the most common disorder affecting the neuromuscular junction
(NMJ). MG is frequently caused by autoantibodies against acetylcholine receptor (AChR) …
(NMJ). MG is frequently caused by autoantibodies against acetylcholine receptor (AChR) …
Autoantibodies to low‐density lipoprotein receptor–related protein 4 in myasthenia gravis
O Higuchi, J Hamuro, M Motomura… - Annals of …, 2011 - Wiley Online Library
Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction, where
acetylcholine receptor (AChR), muscle‐specific kinase (MuSK), and low‐density lipoprotein …
acetylcholine receptor (AChR), muscle‐specific kinase (MuSK), and low‐density lipoprotein …
Anti-LRP4 autoantibodies in AChR-and MuSK-antibody-negative myasthenia gravis
A Pevzner, B Schoser, K Peters, NC Cosma… - Journal of …, 2012 - Springer
Myasthenia gravis (MG) is an autoimmune disorder characterized by a defect in synaptic
transmission at the neuromuscular junction causing fluctuating muscle weakness with a …
transmission at the neuromuscular junction causing fluctuating muscle weakness with a …
Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis
B Zhang, JS Tzartos, M Belimezi, S Ragheb… - Archives of …, 2012 - jamanetwork.com
Objectives To determine whether patients with myasthenia gravis (MG) have serum
antibodies to lipoprotein-related protein 4 (LRP4), a newly identified receptor for agrin that is …
antibodies to lipoprotein-related protein 4 (LRP4), a newly identified receptor for agrin that is …
Induction of anti-agrin antibodies causes myasthenia gravis in mice
Myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular junction (NMJ).
Most cases of MG are caused by autoantibodies against the acetylcholine receptor (AChR) …
Most cases of MG are caused by autoantibodies against the acetylcholine receptor (AChR) …
[HTML][HTML] Myasthenia gravis: pathogenic effects of autoantibodies on neuromuscular architecture
I Koneczny, R Herbst - Cells, 2019 - mdpi.com
Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction (NMJ).
Autoantibodies target key molecules at the NMJ, such as the nicotinic acetylcholine receptor …
Autoantibodies target key molecules at the NMJ, such as the nicotinic acetylcholine receptor …
[HTML][HTML] MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters
A variable proportion of patients with generalized myasthenia gravis (MG) have
autoantibodies to muscle specific tyrosine kinase (MuSK). During development agrin …
autoantibodies to muscle specific tyrosine kinase (MuSK). During development agrin …
MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4
MG Huijbers, W Zhang, R Klooster… - Proceedings of the …, 2013 - National Acad Sciences
Myasthenia gravis (MG) is a severely debilitating autoimmune disease that is due to a
decrease in the efficiency of synaptic transmission at neuromuscular synapses. MG is …
decrease in the efficiency of synaptic transmission at neuromuscular synapses. MG is …
[HTML][HTML] Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms
WD Phillips, A Vincent - F1000Research, 2016 - ncbi.nlm.nih.gov
Myasthenia gravis is an autoimmune disease of the neuromuscular junction (NMJ) caused
by antibodies that attack components of the postsynaptic membrane, impair neuromuscular …
by antibodies that attack components of the postsynaptic membrane, impair neuromuscular …
[HTML][HTML] Myasthenia gravis with antibodies against muscle specific kinase: an update on clinical features, pathophysiology and treatment
M Cao, I Koneczny, A Vincent - Frontiers in Molecular Neuroscience, 2020 - frontiersin.org
Muscle Specific Kinase myasthenia gravis (MuSK-MG) is an autoimmune disease that
impairs neuromuscular transmission leading to generalized muscle weakness. Compared to …
impairs neuromuscular transmission leading to generalized muscle weakness. Compared to …